Famous people don't often get involved with Medicare payment policy, but a Boston Marathon bombing survivor and a former U.S. senator who lost a leg in wartime service have joined an industry campaign to block new requirements for artificial legs and feet.
Danish pharmaceutical giant Novo Nordisk said Wednesday that it has begun Phase III clinical trials of an oral version to its diabetes treatment candidate semaglutide.
Black and Hispanic populations continue to be underrepresented when it comes to the number of graduate medical education trainees, according to a new analysis. The study raises questions as to whether having fewer physicians from underrepresented minorities contributes to the health disparities.
Optometrists are working more closely with physicians and insurers to identify patients' chronic conditions and ensure those patients receive appropriate medical care.
Optometrists are working more closely with physicians and insurers to identify patients' chronic conditions and make sure those patients receive appropriate medical care. They want to demonstrate that they have the training and skills to do more than just fit people for glasses and contact lenses.
We do near miraculous things to diagnose and manage disease in medicine. But do we inspire the rest, recovery and sleep that is fundamental to physical healing and mental well-being?
Researchers have found a correlation between poverty and severe vision loss. They also identified the South as having the most poor people with bad vision. Experts say the problem is not because there is a lack of optometrists.
Successful population health management will require a lot more from the nation's healthcare leaders than merely revamping their systems' delivery models—as difficult as that will be.
Data Points for the week of May 18, 2015, covered the following topics: HIV infection rates, heroin poisoning, mortality among Hispanics with diabetes, physicians with Caribbean medical educations, prescription costs
The FDA is warning that a new class of Type 2 diabetes medications called sodium-glucose cotransporter-2 inhibitors may lead to a serious, potentially fatal condition in which the body overproduces a chemical called ketone and results in too much acid in the blood.
The most expensive 5% of Medicaid beneficiaries nationally accounted for nearly half of program spending from 2009 to 2011, the Government Accountability Office reports.
Merck & Co. said preliminary results of a post-market study of its diabetes drug Januvia showed no increase in hospitalization compared with patients who did not use the drug.